[1]黄绍通.不同浓度碳酸氢钠雾化对COPD患者疗效及真菌感染发生情况分析[J].医学信息,2019,32(24):138-139147.[doi:10.3969/j.issn.1006-1959.2019.24.049]
　HUANG Shao-tong.Analysis of the Effect of Different Concentrations of Sodium Bicarbonate Atomization on Patients with COPD and the Occurrence of Fungal Infections[J].Medical Information,2019,32(24):138-139147.[doi:10.3969/j.issn.1006-1959.2019.24.049]
点击复制

不同浓度碳酸氢钠雾化对COPD患者疗效及真菌感染发生情况分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年24期
页码:
138-139147
栏目:
药物与临床
出版日期:
2019-12-15

文章信息/Info

Title:
Analysis of the Effect of Different Concentrations of Sodium Bicarbonate Atomization on Patients with COPD and the Occurrence of Fungal Infections
文章编号:
1006-1959（2019）24-0138-03
作者:
黄绍通
（赣州市人民医院药剂科，江西 赣州 341000）
Author(s):
HUANG Shao-tong
(Department of Pharmacy,Ganzhou People’s Hospital,Ganzhou 341000,Jiangxi,China)
关键词:
慢性阻塞性肺疾病; 碳酸氢钠; 雾化; 真菌感染
Keywords:
Chronic obstructive pulmonary disease; Sodium bicarbonate; Nebulization; Fungal infection
分类号:
R563
DOI:
10.3969/j.issn.1006-1959.2019.24.049
文献标志码:
A
摘要:
目的 探讨吸入不同浓度的碳酸氢钠溶液雾化治疗对慢性阻塞性肺疾病（COPD）患者的疗效及真菌感染发生情况。方法 选取2017年1月~2018年12月我院呼吸内科收治的COPD患者72例作为研究对象，采用随机数字表法分为A、B、C三组，每组24例。其中A组吸入碳酸氢钠溶液浓度为1.5%，B组吸入浓度为2.5%，C组吸入浓度为5.0%，比较各组患者治疗后第2、4、6 天的24 h排痰量及治疗1周后肺部啰音消失时间、体温恢复正常时间、血常规恢复正常时间、住院天数、肺功能改善情况及治疗前后真菌感染情况。结果 B组患者第4天24 h排痰量多于A组和C组，差异具有统计学意义（P＜0.05）；治疗1周后，B组肺部啰音消失时间、体温恢复正常时间、血常规恢复正常时间、住院天数较A组和C组低，差异具有统计学意义（P＜0.05），而A组和C组比较，差异无统计学意义（P＞0.05）；各组肺功能指标较治疗前有改善，其中B组指标优于A组和C组，差异有统计学意义（P＜0.05）；B组患者口腔真菌感染的发生率为0 ，低于A组（12.50%）和C组（16.67%），差异具有统计学意义（P＜0.05）。结论 COPD患者采用雾化碳酸氢钠吸入有助于提高排痰效果，改善肺功能，缩短患者住院时间，降低口腔真菌感染率，且浓度为2.5%的效果更优，适合在临床应用。
Abstract:
Objective To investigate the effect of inhalation of sodium bicarbonate solution with different concentrations on patients with chronic obstructive pulmonary disease (COPD) and the occurrence of fungal infection. Methods 72 COPD patients admitted to our department of respiratory medicine from January 2017 to December 2018 were selected as the research subjects. They were divided into three groups of A, B and C by random number table method, with 24 cases in each group. The concentration of inhaled sodium bicarbonate solution in group A was 1.5%, the inhaled concentration in group B was 2.5%, and the inhaled concentration in group C was 5.0%. The 24 h sputum output and treatment of patients in each group were compared on day 2, 4, and 6 after treatment. Pulmonary rales disappeared time, body temperature returned to normal time, blood routine returned to normal time, length of hospital stay, lung function improvement and fungal infection before and after treatment.Results Patients in group B had more sputum excretion at 24 h on day 4 than those in groups A and C,the difference was statistically significant (P<0.05);After 1 week of treatment, the time of disappearance of lung rales in group B, time to return to normal body temperature, time to return to normal blood routine, and length of hospital stay were lower than those in groups A and C,the differences were statistically significant (P<0.05);The difference between group A and group C was not statistically significant (P>0.05); the lung function indicators of each group were improved compared with before treatment, and the indicators of group B were better than those of group A and group C,the difference was statistically significant (P<0.05); the incidence of oral fungal infections in group B patients was 0, which was lower than those in group A (12.50%) and group C (16.67%),the difference was statistically significant (P<0.05).Conclusion Inhalation of aerosolized sodium bicarbonate in COPD patients can help improve sputum excretion, improve lung function, shorten the length of hospital stay, and reduce oral fungal infection. The concentration of 2.5% is more effective and suitable for clinical application.

参考文献/References:

[1]饶显群,孙凯.慢性阻塞性肺疾病肺动脉高压的生物标志物及其意义[J].临床急诊杂志,2019(6):498-502.[2]杨中飞,邓芳,杜秀伟,等.慢性阻塞性肺疾病急性加重期患者痰培养真菌检出率及相关因素分析[J].国际医药卫生导报,2019,25(11):1777-1780.[3]中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264.[4]杨晓芸,李涛,任英杰.中重度慢性阻塞性肺疾病稳定期患者C反应蛋白与肺功能急性加重次数的相关性研究[J].山西医药杂志,2019(3):326-328.[5]张松,黄茂.罗红霉素抑制COPD大鼠炎性介质释放对糖皮质激素抵抗的影响[J].实用药物与临床,2018(6):611-614.[6]金福,刘建明.制霉菌素与碳酸氢钠液漱口对老年慢性阻塞性肺疾病患者吸入布地奈德致口腔真菌感染的预防作用比较[J].抗感染药学,2017(8):1602-1604.[7]王庆学,王莉.布地奈德联合盐酸氨溴索雾化吸入治疗毛细支气管炎的疗效分析[J].临床医药文献电子杂志,2017,4(63):12421-12422.[8]徐靓,马丽萍,郑美凤.注射用水加碳酸氢钠持续泵入气道湿化的临床观察[J].临床肺科杂志,2011,16(3):332-334.[9]叶宝霞,冯晓敏,许先成.碳酸氢钠溶液辅助治疗真菌性肺炎的效果[J].中华现代护理杂志,2010,16(33):4046-4047.

相似文献/References:

[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
　ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(24):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
　CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(24):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
　WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Medical Information,2018,31(24):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
　LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(24):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]罗 倩.COPD加重期患者肺功能、血气指标及 炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
　LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Medical Information,2018,31(24):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[7]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病 引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
　ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(24):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[8]金彦青.NPPV治疗慢性阻塞性肺疾病合并 重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
　JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Medical Information,2018,31(24):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[9]何冬兰,李 文.NLR、PLR在慢性阻塞性肺疾病进展、预后中的相关研究[J].医学信息,2022,35(11):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
　HE Dong-lan,LI Wen.Study on Correlation Between NLR and PLR in the Progression and Prognosis of Chronic Obstructive Pulmonary Disease[J].Medical Information,2022,35(24):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
[10]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及 MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
　ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(24):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]

更新日期/Last Update: 2019-12-15